HUTCHMED Gains 5.9% as Divestments Fuel 11-Fold Profit Rise

Edgen Stock·Mar 06 2026, 03:22

Share to

Share to

Copy link

Key Takeaways

HUTCHMED (00013.HK) shares climbed after the company reported a massive increase in net income for 2025, a result driven entirely by the sale of non-core assets. This bottom-line growth overshadowed a significant 13% decline in total revenue from its primary operations, creating a mixed financial picture.

Profitability Surge: Net income soared by 11 times to $457 million, a gain attributed to strategic business disposals.
Revenue Contraction: Total revenue from core operations fell 13% year-over-year to $549 million, indicating underlying business challenges.
Positive Market Reaction: Investors responded favorably to the profit news, sending the stock up 5.9% to HKD22.3 in morning trading.

Stock Climbs 5.9% as Profit Jumps 11-Fold to $457M

Shares of HUTCHMED (00013.HK) gained after the company announced its 2025 financial results on March 5, 2026. The stock opened 0.57% higher and advanced to a peak of HKD22.3, ultimately trading up 5.89% on the day. The move was backed by significant trading activity, with a volume of 1.282 million shares changing hands, representing a total value of HKD28.07 million.

Divestment Gains Mask 13% Decline in Core Revenue

The dramatic jump in profitability was the primary driver of the stock's performance. HUTCHMED reported that its net income grew 11-fold year-over-year to $457 million, with earnings per share reaching $0.53. However, this figure was achieved through a net gain on the disposal of non-core businesses. In contrast, the company's total revenue from operations fell by 13% to $549 million, signaling that the underlying business faced headwinds during the period. This divergence highlights a strategy focused on streamlining operations and unlocking value from non-essential assets rather than organic growth.

Investors Weigh One-Off Gain Against Long-Term Growth

While the market rewarded the sharp increase in net income, the financial results present a complex outlook for investors. The successful divestment strategy boosted the bottom line, but the decline in core revenue raises questions about the long-term growth trajectory of the company's main business lines. Data from March 5 showed short selling activity at $13.75 million, a ratio of 19.16%, suggesting that some market participants remain skeptical about the company's valuation following a profit gain that was not derived from its operational performance.